Mosquito Defensin C Fights Dengue Virus Through the Ras/ERK Immune Signaling Pathway | Research

The takeaway

The Ras/ERK pathway in Aedes mosquitoes activates defensin C to restrict dengue virus replication, revealing how insect antimicrobial peptides fight viral infections.

ERK-specific antiviral
Only ERK (not JNK or p38 MAPK) restricted dengue virus replication via defensin C activation

What the researchers found

Ras/ERK signaling activates defensin C in Aedes mosquitoes to restrict DENV infection; ERK knockdown (but not JNK or p38) significantly enhanced viral replication.

Why it matters

Understanding how mosquitoes naturally fight dengue could lead to strategies for engineering mosquitoes with enhanced viral resistance, reducing dengue transmission to humans.

The numbers in context

ERK knockdown enhanced DENV replication; Ras/ERK activation decreased viral titers; defensin C restricts DENV

How the study worked

Mosquito cell and midgut studies using RNA interference knockdown (ERK, JNK, p38), pharmacological activation/inhibition of Ras/ERK, viral titer measurement, and AMP expression analysis.

Who was studied

Aedes mosquito cells and midgut tissues infected with dengue virus

What this study cannot tell us

Mosquito cell and midgut studies — not whole-organism transmission experiments; defensin C may not be the only AMP involved; applicability to other mosquito-borne viruses unknown.

How to read the evidence

Moderate — multi-approach mechanistic study using genetic and pharmacological methods, but in vitro/ex vivo only.

When this study was published

Published in 2020; engineered mosquito vector control strategies are actively being developed.

The bigger picture

Dengue infects ~400 million people annually. If mosquitoes can be engineered with enhanced Ras/ERK-defensin C pathways, they could be refractory to dengue, blocking transmission at the vector level.

Questions still open

Could transgenic mosquitoes overexpressing defensin C block dengue transmission?
Does this Ras/ERK-AMP crosstalk also restrict Zika, chikungunya, or yellow fever viruses?
Can this pathway be pharmacologically boosted in wild mosquito populations?

Common questions

How do mosquitoes fight viruses?

Mosquitoes have innate immune systems that produce antimicrobial peptides like defensin C to attack viruses. This study shows the Ras/ERK signaling pathway controls this defense against dengue.

Could this help prevent dengue in people?

Not directly, but if researchers can engineer mosquitoes with stronger defensin C responses, those mosquitoes couldn't carry dengue — preventing transmission to humans.

Read the original research

The Ras/ERK signaling pathway couples antimicrobial peptides to mediate resistance to dengue virus in Aedes mosquitoes.

PLoS neglected tropical diseases, 14(8), e0008660

View on PubMed ↗Publisher’s paper ↗

Citation

Liu, Wen-Quan; Chen, Si-Qi; Bai, Hao-Qiang; Wei, Qi-Mei; Zhang, Sheng-Nan; Chen, Chen; Zhu, Yi-Han; Yi, Tang-Wei; Guo, Xiao-Pu; Chen, Si-Yuan; Yin, Meng-Jie; Sun, Chen-Feng; Liang, Shao-Hui. (2020). The Ras/ERK signaling pathway couples antimicrobial peptides to mediate resistance to dengue virus in Aedes mosquitoes.. PLoS neglected tropical diseases, 14(8), e0008660. https://doi.org/10.1371/journal.pntd.0008660